0 Bewertungen
ID

14140

Beschreibung

Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01509755

Link

https://clinicaltrials.gov/show/NCT01509755

Stichworte

Versionen (1)
  1. 31.03.16 31.03.16 -
Hochgeladen am

31. März 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

    Keine Kommentare

    Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

    Eligibility Diabetes NCT01509755

    Englisch

    Eligibility Diabetes NCT01509755

    1 Formulare  
    1. StudyEvent: Eligibility
      1. Eligibility Diabetes NCT01509755
    Inclusion Criteria
    Beschreibung

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    subjects with type 2 diabetes
    Beschreibung

    Type 2 Diabetes

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0011860
    duration of diabetes at least 3 months
    Beschreibung

    Duration of Diabtes

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0872146
    UMLS CUI [1,2]
    C0011860
    both diet treated and patients in therapy with oha (oral hypoglycemic agents)
    Beschreibung

    Diabetic diet and oral hypoglycemic agents

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0011878
    UMLS CUI [2]
    C0359086
    body mass index maximum 40 kg/m^2
    Beschreibung

    Body mass index

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C1305855
    hba1c based on analysis from central laboratory: between 7.5-10.0%, both inclusive, for diet treated, or maximum 9.0% for oha treated
    Beschreibung

    Hba1c

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0019018
    Exclusion Criteria
    Beschreibung

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    liver or renal disease
    Beschreibung

    Liver or renal disease

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0023895
    UMLS CUI [2]
    C0022658
    cardiac problems
    Beschreibung

    Cardiac problems

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0262402
    uncontrolled treated/untreated hypertension
    Beschreibung

    Hypertension

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0020538
    proliferative retinopathy
    Beschreibung

    Proliferative retinopathy

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0339467
    recurrent severe hypoglycaemia as judged by the investigator
    Beschreibung

    Recurrent severe hypoglycaemia

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0342316
    known or suspected allergy to trial product or related products
    Beschreibung

    Allergy to trial product

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0020517
    UMLS CUI [1,2]
    C3854006
    use of any drug (except for ohas) which in the investigator's opinion could interfere with the blood glucose level
    Beschreibung

    Pharmacotherapy interferes with blood glucose level

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0013216
    UMLS CUI [1,2]
    C0521102
    UMLS CUI [1,3]
    C0392201
    Zum Seitenanfang zurückkehren

    Ähnliche Modelle

    Eligibility Diabetes NCT01509755

    1 Formulare
    1. StudyEvent: Eligibility
      1. Eligibility Diabetes NCT01509755
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datentyp
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Type 2 Diabetes
    Item
    subjects with type 2 diabetes
    boolean
    C0011860 (UMLS CUI [1])
    Duration of Diabtes
    Item
    duration of diabetes at least 3 months
    boolean
    C0872146 (UMLS CUI [1,1])
    C0011860 (UMLS CUI [1,2])
    Diabetic diet and oral hypoglycemic agents
    Item
    both diet treated and patients in therapy with oha (oral hypoglycemic agents)
    boolean
    C0011878 (UMLS CUI [1])
    C0359086 (UMLS CUI [2])
    Body mass index
    Item
    body mass index maximum 40 kg/m^2
    boolean
    C1305855 (UMLS CUI [1])
    Hba1c
    Item
    hba1c based on analysis from central laboratory: between 7.5-10.0%, both inclusive, for diet treated, or maximum 9.0% for oha treated
    boolean
    C0019018 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    Liver or renal disease
    Item
    liver or renal disease
    boolean
    C0023895 (UMLS CUI [1])
    C0022658 (UMLS CUI [2])
    Cardiac problems
    Item
    cardiac problems
    boolean
    C0262402 (UMLS CUI [1])
    Hypertension
    Item
    uncontrolled treated/untreated hypertension
    boolean
    C0020538 (UMLS CUI [1])
    Proliferative retinopathy
    Item
    proliferative retinopathy
    boolean
    C0339467 (UMLS CUI [1])
    Recurrent severe hypoglycaemia
    Item
    recurrent severe hypoglycaemia as judged by the investigator
    boolean
    C0342316 (UMLS CUI [1])
    Allergy to trial product
    Item
    known or suspected allergy to trial product or related products
    boolean
    C0020517 (UMLS CUI [1,1])
    C3854006 (UMLS CUI [1,2])
    Pharmacotherapy interferes with blood glucose level
    Item
    use of any drug (except for ohas) which in the investigator's opinion could interfere with the blood glucose level
    boolean
    C0013216 (UMLS CUI [1,1])
    C0521102 (UMLS CUI [1,2])
    C0392201 (UMLS CUI [1,3])
    Zum Seitenanfang zurückkehren 

    Hilfe

    Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

    Zum Video